Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19

  • End date
    Dec 31, 2025
  • participants needed
  • sponsor
    OMNI Medical Services, LLC
Updated on 27 January 2021
brimonidine tartrate ophthalmic solution
disease or disorder
medical marijuana


This will be a multistate, multicenter clinical study to determine the efficacy and safety of medical cannabis for a wide variety of chronic medical conditions.


Medical cannabis has been legal in parts of the USA since 1996, with the stated intention of reducing pain (both acute and chronic) as well as for treatment of multiple other conditions. The original implementation of medical cannabis in the USA was implemented in California as a compassionate measure to treat the HIV/AIDS epidemic. Additional studies have shown promising outcome for patients with multiple sclerosis, seizures, cancer, and other chronic conditions. However, there have been few comprehensive studies that have actually measured whether cannabis is an effective treatment for pain reduction. There is an absence of multistate, multicenter clinical studies with cannabis as medicine, not only in the USA but globally. With the expansion of medical cannabis into more than 38 states in the US, this type of clinical study is now feasible.

On March 11, 2020, the World Health Organization formally characterized coronavirus, COVID-19, as a global pandemic and health systems globally are continuing their efforts to manage the outbreak. Coronavirus disease COVID-19 is an infectious disease caused by a newly discovered coronavirus. With the rapidly growing pandemic of COVID-19 caused by the new and challenging to treat zoonotic SARS-CoV2 coronavirus, there is an urgent need for new therapies and prevention strategies that can help curtail disease spread and reduce mortality. Inhibition of viral entry and thereby spread constitute plausible therapeutic avenues.

This study will utilize an anonymous novel online questionnaire to determine study participants' qualifying condition(s) for medical cannabis use, cannabis ingestion method, frequency of use, prescription drug use, and demographic information. Secondary factors will include evaluation of pain control, quality of life metrics, any adverse side effects from cannabis use, as well as changes in adjunctive treatments. Patients will be given medical cannabis recommendations and certifications commensurate with the state law in which the encounter occurs. The variations in mechanisms between the states for recommending, registering, certifying, and developing mandated treatment plans or doses will be adhered to; however, variations in state law and cannabis programs should not cause variation in the study design because the end-result is still the same with patients being treated with medical cannabis.

Condition Fibromyalgia, Coronavirus Infection, Tourette's Disorder, Seizure, Gastroenteritis, Intestinal Diseases, Tic, Multiple Sclerosis, Myelopathy, Brain Injury, Amyotrophic Lateral Sclerosis, Cancer, Endogenous depression, Depression, Autism, Epilepsy, Insomnia, Bipolar Disorder, Ocular Hypertension, Glaucoma, chronic brain injury, Hepatitis C, Hepatitis C virus, Ulcerative Colitis, Post-Traumatic Stress Disorder, Inflammatory bowel disease, Pain, Crohn's Disease, SICKLE CELL ANEMIA, Severe Acute Respiratory Syndrome, Coronavirus, ANXIETY NEUROSIS, Anxiety, Myofascial Pain Syndrome, Parkinson's disease, Depression (Major/Severe), Chronic Pain, Opioid Use Disorder, Anxiety Disorders (Pediatric), Depression (Adolescent), Depression (Pediatric), Depression (Adult and Geriatric), Post-Traumatic Stress Disorders, Depression (Treatment-Resistant), Generalized Anxiety Disorder (GAD), Cancer/Tumors, Amyotrophic Lateral Sclerosis (ALS), Post-Surgical Pain, Ewing's Family Tumors, Depressed, Generalized Anxiety Disorder (GAD - Pediatric), Chronic Pain Due to Injury, Chronic Pain Syndrome, Pain (Pediatric), Seizure Disorders (Pediatric), Cancer (Pediatric), Crohn's Disease (Pediatric), Ulcerative Colitis (Pediatric), Bipolar Disorders (Pediatric), Corona Virus Infection, Anxiety Symptoms, Radiologically Isolated Syndrome, Chronic Pain Due to Trauma, Autism Spectrum Disorder (ASD), Dermatite Atopique modérée ou grave, Neurology-Tic disorders, fibro, Anxiety Disorders, Manic Disorders, Seizure Disorders, Tourette's Syndrome, Traumatic Brain Injury, Spinal Cord Disorders, Neoplasms, Sickle Cell Disease, Bowel Dysfunction, Tic Disorders, HIV/AIDS, HIV/AIDS, HIV/AIDS, HIV/AIDS, Autism Spectrum Disorder, Brain Injuries, Traumatic, *COVID-19, Covid-19, COVID19, HIV/AIDS, HIV/AIDS, HIV/AIDS, HIV/AIDS, HIV/AIDS, depressive disorder, primary cancer, primary malignant neoplasm, PTSD, seizures, fits, fitting, convulsions, malignancy, cancers, malignancies, malignant tumor, malignant tumors, multiple sclerosis (ms), parkinson's, parkinson disease, inflammatory bowel diseases, chronic traumatic encephalopathy, crohns disease, traumatic brain injury (tbi), anxiety disorder, depressed mood, miserable, chronic pain syndromes, autistic, depressive disorders, anxious, epileptic, seizure disorder, epilepsia, epileptics, tourette syndrome, chronic pains, lou gehrig's disease, HIV/AIDS, HIV/AIDS, HIV/AIDS
Treatment Cannabis, Medical
Clinical Study IdentifierNCT03944447
SponsorOMNI Medical Services, LLC
Last Modified on27 January 2021


Yes No Not Sure

Inclusion Criteria

Clinical diagnosis of a Qualifying Condition for Medical Marijuana
Must be 18 years or older unless they have consent from their parent or legal guardian as defined under state law parameters
Must be willing to complete online surveys at baseline and the follow up points in this study

Exclusion Criteria

Inability to provide informed consent
Inability to complete study visits or questionnaires
Active suicidality or psychosis, that could be exacerbated by the administration of cannabis
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note